The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy-Reference-Cited by-同舟云学术

The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy

Published:2016-12 Issue:5 Volume:96 Page:1011-1020
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Stahl John M.,Ross Rudi,Harder Eileen M.,Mancini Brandon R.,Soulos Pamela R.,Finkelstein Steven E.,Shafman Timothy D.,Dosoretz Arie P.,Evans Suzanne B.,Husain Zain A.,Yu James B.,Gross Cary P.,Decker Roy H.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

2. American College of Chest Physicians. Treatment of stage I non-small cell lung carcinoma;Smythe;Chest,2003

3. Local recurrence after surgery for early stage lung cancer: An 11-year experience with 975 patients;Kelsey;Cancer,2009

4. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer;Grills;J Clin Oncol,2010

5. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consecutive Daily vs. Every Other Day SBRT Scheduling for Stage I NSCLC;Advances in Radiation Oncology;2024-09

2. Clinical association between plan complexity and the local-recurrence-free-survival of non-small-cell lung cancer patients receiving stereotactic body radiation therapy;Physica Medica;2024-06

3. Predicting Regional Recurrence and Prognosis in Stereotactic Body Radiation Therapy-Treated Clinical Stage I Non-small Cell Lung Cancer Using a Radiomics Model Constructed With Surgical Data;International Journal of Radiation Oncology*Biology*Physics;2024-06

4. Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy;Journal of Cancer Research and Clinical Oncology;2024-01-26

5. Deep Learning–Guided Dosimetry for Mitigating Local Failure of Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2023-12